Overview
Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2) to reduce the generation of prostaglandins (PGs) from arachidonic acid. It is approved in more than 60 countries worldwide but not in the US.
Indication
For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.
Associated Conditions
- Ankylosing Spondylitis (AS)
- Gout
- Osteoarthritis (OA)
- Rheumatoid Arthritis
- Moderate Pain
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2021/12/02 | Early Phase 1 | UNKNOWN | |||
2021/07/20 | Phase 3 | Completed | |||
2021/04/05 | Phase 1 | UNKNOWN | |||
2020/09/25 | Phase 2 | Completed | |||
2020/07/08 | Phase 2 | UNKNOWN | Shanghai Yueyang Integrated Medicine Hospital | ||
2019/10/30 | Phase 4 | Completed | |||
2018/07/11 | Phase 4 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | ||
2018/06/01 | Not Applicable | Completed | |||
2018/02/05 | Not Applicable | Completed | Dexa Medica Group | ||
2017/01/05 | Phase 3 | Completed | Oslo University Hospital |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| ETORICOXIB ALVOGEN FILM-COATED TABLETS 120MG | SIN15488P | TABLET, FILM COATED | 120.00mg | 5/21/2018 | |
| BEATROX FILM COATED TABLET 120MG | SIN16963P | TABLET, FILM COATED | 120mg | 2/27/2024 | |
| FORSANEC FILM COATED TABLETS 90mg | SIN16753P | TABLET, FILM COATED | 90mg | 4/4/2023 | |
| ETORICOXIB AUXILTO FILM-COATED TABLETS 90MG | SIN16500P | TABLET, FILM COATED | 90mg | 5/20/2022 | |
| EXINEF TABLET 90 MG | SIN14944P | TABLET, FILM COATED | 90.0 mg | 2/5/2016 | |
| ETORICOXIB ALVOGEN FILM-COATED TABLETS 90MG | SIN15487P | TABLET, FILM COATED | 90.00mg | 5/21/2018 | |
| COXETA FC TABLETS 120MG | SIN16211P | TABLET, FILM COATED | 120 mg | 5/28/2021 | |
| ETORI-90 FILM COATED TABLETS 90 MG | SIN16902P | TABLET, FILM COATED | 90 mg | 11/30/2023 | |
| BEATROX FILM COATED TABLET 90MG | SIN16964P | TABLET, FILM COATED | 90 mg | 2/27/2024 | |
| ETOVITAE FILM COATED TABLET 120MG | SIN16210P | TABLET, FILM COATED | 120.00mg | 5/28/2021 |
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Etoricoxib Tablets | 国药准字H20213566 | 化学药品 | 片剂 | 6/30/2021 | |
| Etoricoxib Tablets | 国药准字HJ20230115 | 化学药品 | 片剂 | 10/18/2023 | |
| Etoricoxib Tablets | 国药准字H20243269 | 化学药品 | 片剂 | 2/23/2024 | |
| Etoricoxib Tablets | 国药准字H20243133 | 化学药品 | 片剂 | 2/6/2024 | |
| Etoricoxib Tablets | 国药准字HJ20181027 | 化学药品 | 片剂 | 9/23/2022 | |
| Etoricoxib Tablets | 国药准字HJ20181029 | 化学药品 | 片剂 | 9/23/2022 | |
| Etoricoxib Tablets | 国药准字H20234006 | 化学药品 | 片剂 | 8/1/2023 | |
| Etoricoxib Tablets | 国药准字H20203710 | 化学药品 | 片剂 | 12/25/2020 | |
| Etoricoxib Tablets | 国药准字H20243132 | 化学药品 | 片剂 | 2/6/2024 | |
| Etoricoxib Tablets | 国药准字H20234178 | 化学药品 | 片剂 | 9/19/2023 |
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| ETORICIP etoricoxib 120 mg tablet blister pack | 281550 | Medicine | A | 10/18/2017 | |
| CIPLA ETORICOXIB etoricoxib 90 mg tablet bottle | 281685 | Medicine | A | 10/18/2017 | |
| ARCOXIA etoricoxib 120mg tablet blister pack | 81458 | Medicine | A | 10/11/2002 | |
| ARCOXIA etoricoxib 60mg tablet blister pack | 81456 | Medicine | A | 10/11/2002 | |
| CIPLA ETORICOXIB etoricoxib 120 mg tablet bottle | 281549 | Medicine | A | 10/18/2017 | |
| ETORICIP etoricoxib 60 mg tablet blister pack | 281680 | Medicine | A | 10/18/2017 | |
| ETORICIP etoricoxib 120 mg tablet bottle | 281551 | Medicine | A | 10/18/2017 | |
| E-COXIP etoricoxib 60 mg tablet bottle | 281683 | Medicine | A | 10/18/2017 | |
| E-COXIP etoricoxib 90 mg tablet bottle | 281689 | Medicine | A | 10/18/2017 | |
| ARCOXIA etoricoxib 30mg tablet blister pack | 131797 | Medicine | A | 4/11/2008 |
Help Us Improve
Your feedback helps us provide better drug information and insights.